RELATLIMAB Pharmacologic Class Indexing
- Class set ID
- 0847f023-1eb2-40ea-8fa3-9f71282fa114
- Version
- 1
- Effective date
- 20230112
- Type
- Indexing - Pharmacologic Class
Mapped DailyMed Labels#
| Label | Manufacturer | Effective | SPL version |
|---|---|---|---|
| These highlights do not include all the information needed to use OPDUALAG safely and effectively. See full prescribing information for OPDUALAG. OPDUALAG™ (nivolumab and relatlimab-rmbw) injection, for intravenous use Initial U.S. Approval: 2022 | E.R. Squibb & Sons, L.L.C. | 20240301 | 2 |